C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2009
12/10/2009	WO2009148015A1 Halogen compound, polycyclic compound, and organic electroluminescence element comprising the polycyclic compound
12/10/2009	WO2009147687A2 An improved process for the separation of enantiomerically pure compounds
12/10/2009	WO2009147011A1 Dibenzofurane polymers for electroluminiscent devices
12/10/2009	WO2009129350A3 A novel process for the preparation of sodium gamma-hydroxybutyrate
12/10/2009	WO2009060318A3 Polymorphic forms of ramelteon and processes for preparation thereof
12/10/2009	WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity
12/10/2009	US20090306415 Method For The Synthesis Of Organic Acid Esters Of 5-Hydroxymethylfurfural And Their Use
12/10/2009	US20090306414 Microchannel Reactor
12/10/2009	US20090306410 Shaped catalyst body for partial oxidation reactions
12/10/2009	US20090306409 Multi-layer catalyst for producing phthalic anhydride
12/10/2009	US20090306408 2-Amino-Bicyclo (3.1.0) Hexane-2,6-Dicarboxylic Ester Derivative
12/10/2009	US20090306329 Novel ester group-containing tetracarboxylic acid dianhydride, novel polyesterimide precursor derived therefrom, and polyesterimide
12/10/2009	US20090306201 Selective inhibitors for transferases
12/10/2009	US20090306200 Prophylactic or Therapeutic Agent for Nocturnal Conduct Disorder Associated With Dementia
12/10/2009	US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/10/2009	US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/10/2009	US20090306022 7-substituted tetracycline compounds
12/10/2009	US20090305891 Cycloalkylphenyl substituted cyclic ketoenols
12/10/2009	US20090305239 Methods and compositions for determing a level of biologically active serum paraoxonase
12/10/2009	US20090304832 Treatment of Parasitic Infections in Humans and Animals
12/10/2009	US20090302743 Material for organic electroluminescence device and organic electroluminescence device using the same
12/10/2009	US20090302284 Reversibly Thermochromic Compositions
12/10/2009	US20090302274 Spirobifluorene derivatives, their preparation and uses thereof
12/10/2009	CA2725749A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
12/09/2009	EP2130826A1 Annulins A, B, C or analogs as indoleamine 2,3-dioxygenase (IDO) inhibitors for treatment of cancer
12/09/2009	EP2130583A1 Method for producing carbonyl compound
12/09/2009	EP2130534A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450
12/09/2009	EP2129654A1 Novel antagonists of the glucagon receptor
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009	EP1392642B1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/09/2009	CN101600702A Spirocyclic tetronic acid derivatives
12/09/2009	CN101600194A A method and system for a low-overhead mobility management protocol in the internet protocol layer
12/09/2009	CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/09/2009	CN100567303C Coumarether compound and use of its composition
12/09/2009	CN100567285C Joglone possessing anti cancer activity and its preparation method
12/09/2009	CN100567282C Preparation and application of N-(2,3-dihydro-2,4-dimethylbenzofuran-5-acyl)-N'-tert-butyl-N'-(substituted benzoyl)hydrazine insecticide
12/09/2009	CN100567281C Water soluble anti-HIV component of radix lithospermi and its extracts
12/09/2009	CN100567269C 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
12/09/2009	CN100567266C Cannabinoid receptor ligands
12/08/2009	US7629493 purifying the antiarrhythmia agent; by dissolving in water mixture which is saturated with at least one water-immiscible solvent and water-miscible solvents, to crystallize at a low temperature; produce on large industrial scales
12/08/2009	US7629492 Halo active aromatic sulfonamide organic compounds and odor control uses therefor
12/08/2009	US7629475 kappa opioid receptors agonist; antidepressants for treating mood disorders, such as depressive disorders and manic disorders, psychological disorders
12/08/2009	US7629471 Transcriptional factor, process for producing the same and use thereof
12/08/2009	US7629381 Such as picropodophyllin, for the inhibition of the insulin-like growth factor-1 receptor; cancer, psoriasis, artherosclerosis and acromegaly
12/08/2009	US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009	US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
12/08/2009	US7629286 from butane via improved of fluid bed vanadium phosphorus mixed oxide catalyst powder which is impregnated with alkyl ester of orthophosphoric
12/08/2009	CA2404725C Extrusion die
12/08/2009	CA2369979C 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/08/2009	CA2296742C Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
12/03/2009	WO2009145286A1 Heterocyclic compound
12/03/2009	WO2009145016A1 Aromatic amine derivative and organic electroluminescent device using the same
12/03/2009	US20090299081 Asymmetric Synthesis of Rocaglamides via Enantioselective Photocycloaddition Mediated by Chiral Bronsted Acids
12/03/2009	US20090299076 Axially asymmetric ester compound and production method thereof
12/03/2009	US20090299061 Fluorescence assays with improved sensitivity
12/03/2009	US20090299009 Method for producing cyclic unsaturated compound
12/03/2009	US20090298949 Aminoalkylphenols, methods of using and making the same
12/03/2009	US20090298934 Diamidine Inhibitors of TDP1
12/03/2009	US20090298899 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); {3-[(4-Chloro-biphenyl-3-carbonyl)-amino]-phenyl}-acetic acid; glaucoma or ocular hypertension; dysmenorrhoea, preterm labour, immune disorders, inflammatory disorders
12/03/2009	US20090298898 Pesticidally active ketone and oxime derivatives
12/03/2009	DE102008025843A1 Verfahren zur Herstellung von Phthalsäureanhydrid A process for preparing phthalic anhydride
12/03/2009	DE102008025834A1 Verfahren zur Herstellung von Maleinsäureanhydrid A process for the production of maleic anhydride
12/03/2009	CA2725680A1 Heterocyclic compound
12/02/2009	EP2128227A1 Monosubstituted furan derivatives via decarboxylation and use thereof as (aviation) fuel
12/02/2009	EP2128226A1 Fuel component
12/02/2009	EP2128217A1 Light-emitting device material and light-emitting device
12/02/2009	EP2128148A1 Compound, alpha 1 adrenaline receptor antagonist, and composition
12/02/2009	EP2125766A1 Benzofuran antiparasitic agents
12/02/2009	EP1831147B1 Method for producing phthalic anhydride
12/02/2009	EP1581477B1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/02/2009	CN101595080A Fluoranthene compound, organic electroluminescent device using the fluoranthene compound, and organic electroluminescent material-containing solution
12/02/2009	CN101594870A 4-aminoquinazoline derivatives and methods of use thereof
12/02/2009	CN101591572A Indirect production method and solubilizing mixing method of biomass liquid fuel
12/02/2009	CN101591507A Green rosin derivatives for electronic industry and method for preparing same
12/02/2009	CN101591314A Ophiobolin di-sesquiterpene compound and preparation method and application thereof
12/02/2009	CN101591313A Modified furfural and furfuralacetone expoxy resin grouting material
12/02/2009	CN100564352C Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
12/02/2009	CN100564344C 2- and 2,5-substituted phenylketo-enols
12/02/2009	CN100564330C Process for recovering organic compounds from aqueous streams containing same
12/02/2009	CN100563826C Non-carrier vanadium-phosphorus-oxygen catalyst and its preparation method and use
12/01/2009	US7626045 Synthesis of himbacine analogs
12/01/2009	US7626044 Plant extracts comprising highly bioactive triptolide derivatives with low toxicity;(5-R)-5-hydroxytriptonide, (5R)-5-hydroxytriptolide, (5R)-5-hydroxy-14-epitriptolide. Delta 5,6-dehydrotriptonide, Delta 5,6-dehydrotriptolide; antiinflammatory agents; immunosuppressants; drug design
12/01/2009	US7626033 Compounds for the modulation of PPARγ activity
12/01/2009	US7625944 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment
12/01/2009	US7625914 2(S)-Ethoxy-3-{4-[2-(3-heptyl-1-methylureido)thiazol-4-yl]phenyl}propanoic acid; dermatology, and cardiovascular diseases, immune diseases, lipid metabolism diseases; veterinary medicine
11/2009
11/26/2009	WO2009142967A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents
11/26/2009	WO2009141718A2 Process for the preparation of prostaglandin analogues and intermediates thereof
11/26/2009	WO2009141166A1 Fuel composition
11/26/2009	WO2009080722A3 Carboxylic derivatives for use in the treatment of cancer
11/26/2009	WO2009035542A3 Guanidine-containing compounds useful as muscarinic receptor antagonists
11/26/2009	US20090292129 Process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest
11/26/2009	US20090292103 Polyamic acid and polyimide
11/26/2009	US20090292014 Benzofuran derivatives useful for treating hyper-proliferative disorders
11/26/2009	US20090291998 Eponemycin and epoxomicin analogs and uses thereof
11/26/2009	CA2724474A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents
11/26/2009	CA2721102A1 Process for the preparation of prostaglandin analogues and intermediates thereof
11/25/2009	EP2123630A1 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative
11/25/2009	EP2123272A1 Adam inhibitor
11/25/2009	EP2121649A1 Method for the production of benzofuran-2-carboxamides
11/25/2009	EP2121648A2 S1p receptor modulating compounds and use thereof

1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 472